Holen Sie sich die Stockscreener-App
0.3998
4.33%
0.0165
Schlusskurs vom Vortag:
$0.3833
Offen:
$0.38
24-Stunden-Volumen:
2.46M
Relative Volume:
1.32
Marktkapitalisierung:
$47.65M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+59.51%
1M Leistung:
+57.07%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.36
$0.42
1-Wochen-Bereich:
$0.2418
$0.44
52-Wochen-Spanne:
$0.193
$6.43
Pomdoctor Ltd Adr Stock (POM) Company Profile
Firmenname
Pomdoctor Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare POM vs HITI, PETS, RDGT, SCNX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
POM
Pomdoctor Ltd Adr
|
0.3998 | 45.69M | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.42 | 213.45M | 424.38M | -36.94M | 9.53M | -0.4206 |
|
PETS
Petmed Express Inc
|
2.38 | 52.00M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
RDGT
Ridgetech Inc
|
1.98 | 36.57M | 119.97M | -1.45M | 632.50K | -0.9847 |
|
SCNX
Scienture Holdings Inc
|
0.5066 | 20.74M | 653.40K | -20.19M | -11.11M | -1.8091 |
Pomdoctor Ltd Adr Aktie (POM) Neueste Nachrichten
US tries 'Monkey Scaring' To Rid Wall Street Of Suspicious Chinese Listings - Benzinga
POM INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026 - ChartMill
POM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026 - Sahm
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines – POM - ChartMill
Shareholders who lost money in American Depositary Receipts - GlobeNewswire
ROSEN, A LONGSTANDING FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ROSEN, NATIONAL TRIAL LAWYERS, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit - Barchart.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming DeadlinesPOM - ChartMill
UPCOMING DEADLINE: Pomdoctor Limited (POM) Securities Fraud Class Action – April 13, 2026 Lead Plaintiff Deadline - ChartMill
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
POM CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - ChartMill
POM Investors with Large Losses Should Contact Robbins LLP for Information About the POMDoctor Ltd. Securities Class Action Lawsuit - Barchart.com
Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately - Barchart.com
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against PomDoctor, Ltd. (NASDAQ: POM) - ChartMill
POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026 - Sahm
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
POM INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - ChartMill
ROSEN, LEADING INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
POM SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026 - ChartMill
POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - Sahm
POM Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against POMDoctor Ltd. - Barchart.com
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit - ChartMill
POM SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - Sahm
Rosen Law Firm Urges PomDoctor Ltd. (NASDAQ: POM) Stockholders to Contact the Firm for Information About Their Rights - ChartMill
Pomdoctor Deepens Medical Insurance Integration to Expand Online Chronic-Care Reach Across Major Chinese Cities - TipRanks
Pomdoctor Receives Nasdaq Deficiency Notice Over Minimum Bid Price - TipRanks
Pomdoctor expands online hospital business through pharma partnerships By Investing.com - Investing.com India
Pomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expansion in China - TipRanks
United States shares higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com India
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com UK
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com
Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative - Sahm
Pomdoctor Limited Reports Strong Revenue Growth Amidst Challenging Conditions - TipRanks
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday - Benzinga
Citi (NYSE: C) extends Token Services in Dublin with Euro transfers, 24/7 liquidity - Stock Titan
Citi (NYSE: C) lowers base lending rate to 7.00%, effective Oct 30 at Citibank, N.A. - Stock Titan
Diluted shares outstanding of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
Citi Appointed as Depositary Bank for POMDOCTOR LIMITED’s ADR Program - The AI Journal
Finanzdaten der Pomdoctor Ltd Adr-Aktie (POM)
Es liegen keine Finanzdaten für Pomdoctor Ltd Adr (POM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):